Opioidergic and dopaminergic manipulation of gambling tendencies: A preliminary study in male recreational gamblers

Frontiers in Behavioral Neuroscience

Volumn , Issue OCT, 2013, Pages

  Porchet, Roseline I ^a,b   Boekhoudt, Linde ^a   Studer, Bettina ^a,b,c   Gandamaneni, Praveen K ^a,d   Rani, Nisha ^a,d   Binnamangala, Somashekar ^a,d   Müller, Ulrich ^a,b   Clark, Luke ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Addiction; Decision making; Haloperidol; Motivation; Naltrexone; Pathological gambling; Psychophysiology; Reward

Indexed keywords

HALOPERIDOL; NALTREXONE; PROLACTIN;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTRODERMAL RESPONSE; GAMBLING; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NEUROMODULATION; NORMAL HUMAN; PROLACTIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE;

EID: 84886257647     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2013.00138     Document Type: Article

References (106)

1. Akitsuki, Y., Sugiura, M., Watanabe, J., Yamashita, K., Sassa, Y., Awata, S., et al. (2003). Context-dependent cortical activation in response to financial reward and penalty: an event-related fMRI study. Neuroimage 19, 1674-1685. doi: 10. 1016/S1053-8119(03)00250-7
2. Ayton, P., and Fischer, I. (2004). The hot hand fallacy and the gambler's fallacy: two faces of subjective randomness? Mem. Cogn. 32, 1369-1378. doi: 10.3758/BF03 206327
3. Barbano, M. F., and Cador, M. (2007). Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology 191, 497-506. doi: 10.1007/s00213-006-0521-1
4. Ben-Jonathan, N., and Hnasko, R. (2001). Dopamine as a prolactin (PRL) inhibitor. Endocr. Rev. 22, 724-763. doi: 10.1210/er.22.6.724
5. Bergh, C., Eklund, T., Sodersten, P., and Nordin, C. (1997). Altered dopamine function in pathological gambling. Psychol. Med. 27, 473-475. doi: 10.1017/S0033291796 003789
6. Billieux, J., van der Linden, M., Khazaal, Y., Zullino, D., and Clark, L. (2012). Trait gambling cognitions predict near-miss experiences and persistence in laboratory slot machine gambling. Br. J. Psychol. 103, 412-427. doi: 10.1111/j.2044-8295.2011.02083.x
7. Bland, R. C., Newman, S. C., Orn, H., and Stebelsky, G. (1993). Epidemiology of pathological gambling in Edmonton. Can. J. Psychiatry 38, 108-112.
8. Boettiger, C. A., Kelley, E. A., Mitchell, J. M., D'Esposito, M., and Fields, H. L. (2009). Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network. Pharmacol. Biochem. Behav. 93, 291-299. doi: 10.1016/j.pbb.2009. 02.008
9. Bond, A., and Lader, M. (1974). The use of analogue scales in rating subjective feelings. Br. J. Psychol. 47, 211-218. doi: 10.1111/j.2044-8341. 1974.tb02285.x
10. Bradley, M. M. (2000). "Emotion and Motivation," in Handbook of Psychophysiology 2nd Edn., eds J. T. Cacioppo, L. G. Tassinary, and G. G. Berntson (New York, NY: Cambridge University Press), 602-642.
11. Cardinal, R. N., and Aitken, M. R. F. (2006). ANOVA for the Behavioural Sciences Researcher. New Jersey: Lawrence Erlbaum Associates.
12. Chamberlain, S. R., Müller, U., Blackwell, A. D., Clark, L., Robbins, T. W., and Sahakian, B. J. (2006). Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311, 861-863. doi: 10.1126/science.1121218
13. Chase, H. W., and Clark, L. (2010). Gambling severity predicts midbrain response to near-miss outcomes. J. Neurosci. 30, 6180-6187. doi: 10.1523/JNEURO SCI.5758-09.2010
14. Clark, L. (2010). Decision-making during gambling: an integration of cognitive and psychobiological approaches. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365, 319-330. doi: 10.1098/rstb.2009.0147
15. Clark, L., Crooks, B., Clarke, R., Aitken, M. R., and Dunn, B. D. (2012a). Physiological responses to near-miss outcomes and personal control during simulated gambling. J. Gambl. Stud. 28, 123-137. doi: 10.1007/s10899-011-9247-z
16. Clark, L., Li, R., Wright, C. M., Rome, F., Fairchild, G., Dunn, B. D., et al. (2012b). Risk-avoidant decision making increased by threat of electric shock. Psychophysiology 49, 1436-1443. doi: 10.1111/j.1469-8986.2012.01454.x
17. Clark, L., Lawrence, A. J., Astley-Jones, F., and Gray, N. (2009). Gambling near-misses enhance motivation to gamble and recruit win-related brain circuitry. Neuron 61, 481-490. doi: 10.1016/j.neuron. 2008.12.031
18. Clark, L., Liu, R., McKavanagh, R., Garrett, A., Dunn, B. D., and Aitken, M. R. (2013). Learning and affect following near-miss outcomes in simulated gambling. J. Behav. Dec. Making. doi: 10.1002/bdm.1774
19. Coricelli, G., Critchley, H. D., Joffily, M., O'Doherty, J. P., Sirigu, A., and Dolan, R. J. (2005). Regret and its avoidance: a neuroimaging study of choice behavior. Nat. Neurosci. 8, 1255-1262. doi: 10.1038/nn1514
20. Crabtree, B. L. (1984). Review of nal-trexone, a long-acting opiate antagonist. Clin. Pharm. 3, 273-280.
21. Cyders, M. A., Smith, G. T., Spillane, N. S., Fischer, S., Annus, A. M., and Peterson, C. (2007). Integration of impulsivity and positive mood to predict risky behavior: development and validation of a measure of positive urgency. Psychol. Assess. 19, 107-118. doi: 10.1037/1040-3590. 19.1.107
22. Darby, J. K., Pasta, D. J., Dabiri, L., Clark, L., and Mosbacher, D. (1995). Haloperidol dose and blood level variability: toxicity and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting. J. Clin. Psychopharmacol. 15, 334-340. doi: 10.1097/00004714-199510000-00005
23. Davidson, D., Palfai, T., Bird, C., and Swift, R. (1999). Effects of naltrex-one on alcohol self-administration in heavy drinkers. Alc. Clin. Exp. Res. 23, 195-203. doi: 10.1111/j.1530-0277.1999.tb04099.x
24. Dawson, M. E., Schell, A. M., and Filion, D. L. (2000). "The elec-trodermal system," in Handbook of Psychophysiology, 2nd Edn., eds J. T. Cacioppo, L. G. Tassinary, and G. G. Berntson (New York, NY: Cambridge University Press), 200-223.
25. Declerck, C. H., Boone, C., and De Brabander, B. (2006). On feeling in control: a biological theory for individual differences in control perception. Brain Cogn. 62, 143-176. doi: 10.1016/j.bandc.2006.04.004
26. Dixon, M. J., Harrigan, K. A., Jarick, M., Maclaren, V., Fugelsang, J. A., and Sheepy, E. (2011). Psychophysiological arousal signatures of near-misses in slot machine play. Int. Gamb. Stud. 11, 1-14. doi: 10.1080/14459795.2011.603134
27. Djamshidian, A., Cardoso, F., Grosset, D., Bowden-Jones, H., and Lees, A. J. (2011). Pathological gambling in Parkinson's disease-a review of the literature. Mov. Disord. 26, 1976-1984. doi: 10.1002/mds.23821
28. Drewnowski, A., Krahn, D. D., Demitrack, M. A., Nairn, K., and Gosnell, B. A. (1995). Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters. Am. J. Clin. Nutr. 61, 1206-1212.
29. Drobes, D. J., Anton, R. F., Thomas, S. E., and Voronin, K. (2004). Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers. Alc. Clin. Exp. Res. 28, 1362-1370. doi: 10. 1097/01.ALC.0000139704.88862.01
30. Elliott, R., Friston, K. J., and Dolan, R. J. (2000). Dissociable neural responses in human reward systems. J. Neurosci. 20, 6159-6165.
31. Emond, M. S., and Marmurek, H. H. (2010). Gambling related cognitions mediate the association between thinking style and problem gambling severity. J. Gambl. Stud. 26, 257-267. doi: 10.1007/s10899-009-9164-6
32. Ferris, J., and Wynne, H. (2001). Canadian Problem Gambling Index. Ottawa, Ontario: Canadian Centre on Substance Abuse.
33. Fortune, E. E., and Goodie, A. S. (2012). Cognitive distortions as a component and treatment focus of pathological gambling: a review. Psychol. Addict. Behav. 2012, 298-310. doi: 10.1037/a0026422
34. Frank, M. J., and O'Reilly, R. C. (2006). A mechanistic account of striatal dopamine function in human cognition: psychopharmacologi-cal studies with cabergoline and haloperidol. Behav. Neurosci. 120, 497-517. doi: 10.1037/0735-7044. 120.3.497
35. Freeman, M. E., Kanyicska, B., Lerant, A., and Nagy, G. (2000). Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 80, 1523-1631.
36. Gainsbury, S., and Blaszczynski, A. (2011). The appropriateness of using laboratories and student participants in gambling research. J. Gambl. Stud. 27, 83-97. doi: 10. 1007/s10899-010-9190-4
37. Gilovich, T., Vallone, R., and Tversky, A. (1985). The hot hand in bas ketball: on the misperception of random sequences. Cognit. Psychol. 17, 295-314. doi: 10.1016/0010- 0285(85)90010-6
38. Giuliano, C., Robbins, T. W., Nathan, P. J., Bullmore, E. T., and Everitt, B. J. (2012). Inhibition of opioid transmission at the mu-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology 37, 2643-2652. doi: 10.1038/npp.20 12.128
39. Grace, A. A. (1991). Phasic versus tonic dopamine release and the modulation of dopamine system respon-sivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1-24. doi: 10.1016/0306-4522 (91)90196-U
40. Grant, J. E., Kim, S. W., Hollander, E., and Potenza, M. N. (2008). Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology 200, 521-527. doi: 10.1007/s00213-008-1235-3
41. Grant, J. E., Potenza, M. N., Hollander, E., Cunningham-Williams, R., Nurminen, T., Smits, G., et al. (2006). Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am. J. Psychiatry 163, 303-312. doi: 10.1176/appi.ajp.163. 2.303
42. Habib, R., and Dixon, M. R. (2010). Neurobehavioral evidence for the "Near-Miss" effect in pathological gamblers. J. Exp. Anal. Behav. 93, 313-328. doi: 10.1901/jeab.20 10.93-313
43. Hodes, R. L., Cook, E. W. 3rd., and Lang, P. J. (1985). Individual differences in autonomic response: conditioned association or conditioned fear? Psychophysiology 22, 545-560. doi: 10.1111/j.1469-8986.1985.tb01649.x
44. Ignar, D. M., Goetz, A. S., Noble, K. N., Carballo, L. H., Stroup, A. E., Fisher, J. C., et al. (2011). Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist. J. Pharmacol. Exp. Ther. 339, 24-34. doi: 10.1124/jpet.111.180943
45. Joutsa, J., Johansson, J., Niemela, S., Ollikainen, A., Hirvonen, M. M., Piepponen, P., et al. (2012). Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage 60, 1992-1999. doi: 10.1016/j.neuroimage.2012.02.006
46. Kapur, S., Remington, G., Jones, C., Wilson, A., DaSilva, J., Houle, S., et al. (1996). High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am. J. Psychiatry 153, 948-950.
47. Kassinove, J. I., and Schare, M. L. (2001). Effects of the "near miss" and the "big win" on persistence at slot machine gambling. Psychol. Addict. Behav. 15, 155-158. doi: 10.1037/0893-164X.15.2.155
48. Katzen-Perez, K. R., Jacobs, D. W., Lincoln, A., and Ellis, R. J. (2001). Opioid blockade improves human recognition memory following physiological arousal. Pharmacol. Biochem. Behav. 70, 77-84. doi: 10.1016/S0091-3057(01)00589-5
49. Kim, S. W., Grant, J. E., Adson, D. E., and Shin, Y. C. (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol. Psychiatry 49, 914-921. doi: 10.1016/S0006-3223(01)01079-4
50. Kreek, M. J. (1996). Opiates, opioids and addiction. Mol. Psychiatry 1, 232-254.
51. Krishnan-Sarin, S., Krystal, J. H., Shi, J., Pittman, B., and O'Malley, S. S. (2007). Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol. Psychiatry 62, 694-697. doi: 10.1016/j.biopsych.2006.11.018
52. Ladouceur, R., Sevigny, S., Blaszczynski, A., O'Connor, K., and Lavoie, M. E. (2003). Video lottery: winning expectancies and arousal. Addiction 98, 733-738. doi: 10.1046/j.1360-0443.2003.00412.x
53. Ladouceur, R., and Walker, M. (1996). "A cognitive perspective on gambling," in Trends in Cognitive and Behavioural Therapies, eds P. M. Salkovskis (Chichester: Wiley and Sons), 89-120.
54. Langer, E. J. (1975). The illusion of control. J. Pers. Soc. Psychol. 32, 311-328. doi: 10.1037/0022-3514. 32.2.311
55. Langleben, D. D., Busch, E. L., O'Brien, C. P., and Elman, I. (2012a). Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence. Psychopharmacology 220, 559-564. doi: 10.1007/s00213-011-2503-1
56. Langleben, D. D., Ruparel, K., Elman, I., Loughead, J. W., Busch, E. L., Cornish, J., et al. (2012b). Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients. Addict. Biol. doi: 10.1111/j.1369-1600.2012. 00462.x. [Epub ahead of print].
57. Leeman, R. F., and Potenza, M. N. (2012). Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology 219, 469-490. doi: 10.1007/s00213-011-2550-7
58. Limbrick-Oldfield, E. H., Van Holst, R. J., and Clark, L. (2013). Fronto-striatal dysregulation in drug addiction and pathological gambling: consistent inconsistencies? Neuroimage Clin. 2, 385-393. doi: 10.1016/j.nicl.2013.02.005
59. Linnet, J., Moller, A., Peterson, E., Gjedde, A., and Doudet, D. (2011). Dopamine release in ventral stria-tum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction 106, 383-390. doi: 10.1111/j.1360-0443.2010.03126.x
60. Lobo, D. S., and Kennedy, J. L. (2009). Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities. Addiction 104, 1454-1465. doi: 10.1111/j.1360-0443.2009.02671.x
61. Lole, L., Gonsalvez, C. J., Blaszczynski, A., and Clarke, A. R. (2012). Electrodermal activity reliably captures physiological differences between wins and losses during gambling on electronic machines. Psychophysiology 49, 154-163. doi: 10.1111/j.1469-8986.2011.01290.x
62. Martin-Soelch, C., Szczepanik, J., Nugent, A., Barhaghi, K., Rallis, D., Herscovitch, P., et al. (2011). Lateralization and gender differences in the dopaminergic response to unpredictable reward in the human ventral striatum. Eur. J. Neurosci. 33, 1706-1715. doi: 10.1111/j.1460-9568.2011.07642.x
63. Meyer, G., Schwertfeger, J., Exton, M. S., Janssen, O. E., Knapp, W., Stadler, M. A., et al. (2004). Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology 29, 1272-1280. doi: 10.1016/j.psy neuen.2004.03.005
64. Meyer, M. C., Straughn, A. B., Lo, M. W., Schary, W. L., and Whitney, C. C. (1984). Bioequivalence, dose-proportionality, and pharma-cokinetics of naltrexone after oral administration. J. Clin. Psychiatry 45, 15-19.
65. Michalczuk, R., Bowden-Jones, H., Verdejo-Garcia, A., and Clark, L. (2011). Impulsivity and cognitive distortions in pathological gamblers attending the UK National Problem Gambling Clinic: a preliminary report. Psychol. Med. 41, 2625-2635. doi: 10.1017/ S003329171100095X
66. Miller, N. V., and Currie, S. R. (2008). A Canadian population level analysis of the roles of irrational gambling cognitions and risky gambling practices as correlates of gambling intensity and pathological gambling. J. Gambl. Stud. 24, 257-274. doi: 10.1007/s10899-008-9089-5
67. Miranda, R., Ray, L., Blanchard, A., Reynolds, E. K., Monti, P. M., Chun, T., et al. (2013). Effects of nal-trexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addict. Biol. doi: 10.1111/adb.12050. [Epub ahead of print].
68. Mitchell, J. M., Liang, M. T., and Fields, H. L. (2005). A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology 182, 384-392. doi: 10.1007/s00213-005-0067-7
69. Mitchell, J. M., Tavares, V. C., Fields, H. L., D'Esposito, M., and Boettiger, C. A. (2007). Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls. Neuropsychopharmacology 32, 439-449. doi: 10.1038/sj.npp.13 01226
70. Moore, J. W., Schneider, S. A., Schwingenschuh, P., Moretto, G., Bhatia, K. P., and Haggard, P. (2010). Dopaminergic medication boosts action-effect binding in Parkinson's disease. Neuropsychologia 48, 1125-1132. doi: 10.1016/j.neuropsychologia. 2009.12.014
71. Myrick, H., Anton, R. F., Li, X., Henderson, S., Randall, P. K., and Voronin, K. (2008). Effect of nal-trexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch. Gen. Psychiatry 65, 466-475. doi: 10.1001/archpsyc.65. 4.466
72. Niv, Y., Daw, N. D., Joel, D., and Dayan, P. (2007). Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology (Berl.) 191, 507-520. doi: 10.1007/ s00213-006-0502-4
73. O'Brien, C. P. (2005). Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am. J. Psychiatry 162, 1423-1431. doi: 10.1176/appi.ajp. 162.8.1423
74. Oei, N. Y., Rombouts, S. A., Soeter, R. P., van Gerven, J. M., and Both, S. (2012). Dopamine modulates reward system activity during subconscious processing of sexual stimuli. Neuropsychopharmacology 37, 1729-1737. doi: 10.1038/npp. 2012.19
75. Orgaz, C., Estevez, A., and Matute, H. (2013). Pathological gamblers are more vulnerable to the illusion of control in a standard associative learning task. Front. Psychol. 4:306. doi: 10.3389/fpsyg.2013.00306
76. Oskarsson, A. T., Van Boven, L., McClelland, G. H., and Hastie, R. (2009). What's next? Judging sequences of binary events. Psychol. Bull. 135, 262-285. doi: 10.1037/ a0014821
77. Pecina, S., Smith, K. S., and Berridge, K. C. (2006). Hedonic hot spots in the brain. Neuroscientist 12, 500-511. doi: 10.1177/1073858406293154
78. Pessiglione, M., Seymour, B., Flandin, G., Dolan, R. J., and Frith, C. D. (2006). Dopamine-dependent prediction errors underpin reward- seeking behavior in humans. Nature 442, 1042-1045. doi: 10.1038/ nature05051
79. Petrovic, P., Pleger, B., Seymour, B., Kloppel, S., De Martino, B., Critchley, H., et al. (2008). Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses. J. Neurosci. 28, 10509-10516. doi: 10.1523/ JNEUROSCI.2807-08.2008
80. Petry, N. M., Blanco, C., Auriacombe, M., Borges, G., Bucholz, K., Crowley, T. J., et al. (2013). An overview of and rationale for changes proposed for pathological gambling in DSM-5. J. Gambl. Stud. doi: 10.1007/s10899-013-9370-0. [Epub ahead of print].
81. Pine, A., Shiner, T., Seymour, B., and Dolan, R. J. (2010). Dopamine, time, and impulsivity in humans. J. Neurosci. 30, 8888-8896. doi: 10.1523/JNEUROSCI.6028-09.2010
82. Pleger, B., Ruff, C. C., Blankenburg, F., Kloppel, S., Driver, J., and Dolan, R. J. (2009). Influence of dopaminergically mediated reward on somatosensory decision-making. PLoS Biol. 7:e1000164. doi: 10.1371/journal.pbio.1000164
83. Potenza, M. N. (2008). The neurobi-ology of pathological gambling and drug addiction: an overview and new findings. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363, 3181-3189. doi: 10.1098/rstb.2008.0100
84. Ray, L. A., and Hutchison, K. E. (2007). Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch. Gen. Psychiatry 64, 1069-1077. doi: 10.1001/archpsyc. 64.9.1069
85. Raylu, N., and Oei, T. P. (2004). The Gambling Related Cognitions Scale (GRCS): development, confirmatory factor validation and psychometric properties. Addiction 99, 757-769. doi: 10.1111/j.1360-0443. 2004.00753.x
86. Redgrave, P., and Gurney, K. (2006). The short-latency dopamine signal: a role in discovering novel actions? Nat. Rev. Neurosci. 7, 967-975. doi: 10.1038/nrn2022
87. Reid, R. L. (1986). The psychology of the near miss. J. Gambl. Behav. 2, 32-39. doi: 10.1007/BF01019932
88. Shaffer, H. J., Hall, M. N., and Vander Bilt, J. (1999). Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am. J. Public Health 89, 1369-1376. doi: 10.2105/AJPH.89.9.1369
89. Shaw, D., and Al'Absi, M. (2010). Blunted opiate modulation of prolactin response in smoking men and women. Pharmacol. Biochem. Behav. 95, 1-5. doi: 10.1016/j.pbb.2009.11.016
90. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini- International Neuropsychiatric Interview (M.I.N.I.): the develop ment and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59(Suppl. 20), 22-33.
91. Spanagel, R., Herz, A., and Shippenberg, T. S. (1992). Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 89, 2046-2050. doi: 10.1073/pnas.89.6.2046
92. Steeves, T. D., Miyasaki, J., Zurowski, M., Lang, A. E., Pellecchia, G., Van Eimeren, T., et al. (2009). Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132, 1376-1385. doi: 10.1093/brain/awp054
93. Studer, B., Apergis-Schoute, A. M., Robbins, T. W., and Clark, L. (2012). What are the odds? The neural correlates of active choice during gambling. Front. Neurosci. 6:46. doi: 10.3389/fnins.2012.00046
94. Studer, B., and Clark, L. (2011). Place your bets: psychophysiological correlates of decision-making under risk. Cogn. Aff. Behav. Neurosci. 11, 144-158. doi: 10.3758/s13415-011-0025-2
95. Toce-Gerstein, M., Gerstein, D. R., and Volberg, R. A. (2003). A hierarchy of gambling disorders in the community. Addiction 98, 1661-1672. doi: 10.1111/j.1360-0443.2003.00545.x
96. Volkow, N. D., and Swanson, J. M. (2003). Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psychiatry 160, 1909-1918. doi: 10.1176/appi.ajp.160.11.1909
97. Voon, V., Fernagut, P. O., Wickens, J., Baunez, C., Rodriguez, M., Pavon, N., et al. (2009). Chronic dopamin-ergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol. 8, 1140-1149. doi: 10.1016/S1474-4422(09)70287-X
98. Wardle, H., Moody, A., Spence, S., Orford, J., Volberg, R., Jotangia, D., et al. (2010). British Gambling Prevalence Survey. London: National Centre for Social Research.
99. Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., et al. (2010). Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67, 589-595. doi: 10.1001/archneurol. 2010.65
100. Winstanley, C. A., Cocker, P. J., and Rogers, R. D. (2011). Dopamine modulates reward expectancy during performance of a slot machine task in rats: evidence for a 'near-miss' effect. Neuropsychopharmacology 36, 913-925. doi: 10.1038/npp. 2010.230
101. Xiberas, X., Martinot, J. L., Mallet, L., Artiges, E., Loc, H. C., Maziere, B., et al. (2001). Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Br. J. Psychiatry 179, 503-508. doi: 10.1192/bjp.179.6.503
102. Zack, M., and Poulos, C. X. (2004). Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 29, 195-207. doi: 10.1038/sj.npp.13 00333
103. Zack, M., and Poulos, C. X. (2007). A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacology 32, 1678-1686. doi: 10.1038/sj.npp.13 01295
104. Zack, M., and Poulos, C. X. (2009). Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity. J. Psychopharmacol. 23, 660-671. doi: 10.1177/0269881108091072
105. Zald, D. H., Boileau, I., El-Dearedy, W., Gunn, R., McGlone, F., Dichter, G. S., et al. (2004). Dopamine transmission in the human striatum during monetary reward tasks. J. Neurosci. 24, 4105-4112. doi: 10.1523/JNEUROSCI.4643-03.2004
106. Zhu, J., Spencer, T. J., Liu-Chen, L. Y., Biederman, J., and Bhide, P. G. (2011). Methylphenidate and mu opioid receptor interactions: a pharmacological target for prevention of stimulant abuse. Neuropharmacology 61, 283-292. doi: 10.1016/j.neuropharm.2011. 04.015